Our History

2011
Dishman Bavla HIGH POTENT API manufacturing facility will come on stream. Dishman Shanghai facility is nearing completion of an upgrade to manufacture large scale HIGH POTENT APIS at the site.

2010
Construction of Dishman Shanghai manufacturing facility is finished.

2007
Formation of Dishman Japan. Acquisition of Solvay Vitamins and Chemicals business based in the Netherlands.

2006
Acquisition of CARBOGEN AMCIS, Swiss-based Contract Research and Manufacturing Organisation. Formation of Dishman China.

2005
Acquisition of IO3S, Swiss-based ozone technology specialists.

2004
Dishman IPO on Indian Stock Exchange.

2001
First commercial contract manufacturing agreement signed with a major western pharmaceutical company.

1998
Establishment of Dishman Europe and Dishman USA sales subsidiaries.

1996
Initiation of Bavla facility for bulk intermediates.

1995
Formation of a joint venture company with Schütz & Co., called Schütz Dishman Biotech Private Ltd. Manufacture of chlorhexidine and derivates for European market.

1989
Production of a range of phase transfer catalysts and quats at Naroda facility.

1983
Incorporation of Dishman Pharmaceuticals and Chemicals Limited.

News

11 August 2016
Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS

2 February 2016
Dishman Netherlands awarded for its Corporate Social Responsibility.

24 September 2015
Dishman has been awarded manufacture of SIRTURO® (bedaquiline) API

9 February 2015
Successful FDA inspection at the Netherlands Dishman site

VIEW NEWS ARCHIVE